Genetic Engineering News

<img alt="" height="1" width="1" />
Repros gets clearance for new trial of Proellex
Repros Therapeutics Inc. said Friday that regulators will allow it to conduct a new study of its drug candidate Proellex, which has been stalled for almost a year because of concerns about its effects on the liver of patients. ...
Repros shares jump on Proellex newsHouston Business Journal
FDA lifts Proellex clinical hold; NJ biotech stays strong through recession;FierceBiotech
June 11 (Reuters) - Some small and midcap stocks on the move Friday:Reuters
Genetic Engineering News -MarketWatch (press release) -Penny Stock Live (blog)
all 47 news articles &raquo;